Virtual Medicinal Product (VMP)
-
Dinoprostone 1mg/2.5ml vaginal gel
Name Details
Current Name
Dinoprostone 1mg/2.5ml vaginal gel
|
Start Date
01-02-2010
|
End Date
|
Previous Name
Dinoprostone 400micrograms/ml vaginal gel
|
Start Date
20-05-2003
|
End Date
31-01-2010
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- applicator
- Unit Dose UOM
- applicator
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Vaginal
- Form
- Vaginal gel
- Ontology Form/Route
- gel.vaginal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G02AD02
BNF |
Current BNF
07010100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
07010100
|
Start Date
01-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41739111000001101 |
02-05-2023 |
|
326119009 |
20-05-2003 |
01-05-2023 |
VMP Ingredients
VMP ingredients table
Dinoprostone |
Based on Ingredient Substance |
|
400 microgram |
1 ml |
Name
Dinoprostone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
400.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Dinoprostone
-
VMP
(Current) Dinoprostone 1mg/2.5ml vaginal gel
Virtual Medicinal Product Pack (VMPP) Information